المؤلفون: Wang, G, Li, Y, Xiong, C, McDade, E, Clifford, DB, Mills, SL, Santacruz, AM, Aschenbrenner, AJ, Hassenstab, J, Benzinger, TLS, Gordon, BA, Fagan, AM, Coalier, KA, Libre-Guerra, JJ, McCullough, A, Joseph-Mathurin, N, Chen, CD, Mummery, C, Wendelberger, BA, Gauthier, S, Masellis, M, Holdridge, KC, Yaari, R, Chatterjee, S, Sims, J, Delmar, P, Kerchner, GA, Bittner, T, Hofmann, C, Bateman, RJ

المصدر: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring , 14 (1) , Article e12367. (2022)

مصطلحات موضوعية: Dominantly Inherited Alzheimer Network, autosomal dominant Alzheimer's disease, dose escalation, gantenerumab, solanezumab

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10181644/1/Evaluation%20of%20dose-dependent%20treatment%20effects%20after%20mid-trial%20dose%20escalation%20in%20biomarker,%20clinical,%20and%20cognitive%20outcome.pdf; https://discovery.ucl.ac.uk/id/eprint/10181644/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10181644/1/Evaluation%20of%20dose-dependent%20treatment%20effects%20after%20mid-trial%20dose%20escalation%20in%20biomarker,%20clinical,%20and%20cognitive%20outcome.pdf
https://discovery.ucl.ac.uk/id/eprint/10181644/